• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ABB
Click for more information
0.27% $3.73

AUSSIE BROADBAND LIMITED - News & Media

Market Cap $1.100B  ! watchlist Created with Sketch. Add to my watchlist
Communication Services Telecom Services

Aussie Broadband Limited is an Australia-based operating as a national carrier of... Aussie Broadband Limited is an Australia-based operating as a national carrier of telecommunications and technology services in Australia, servicing residential, business, wholesale and enterprise and government customers. Its segments include Residential, Business, Wholesale, Enterprise and Government, and Symbio. The Residential segment provides telecommunications services to residential users. The Business segment provides telecommunications services to business users. The Wholesale segment provides telecommunication services to third party resellers. The Enterprise and Government segment provides telecommunications services to large enterprises including those in the public sector. Symbio segment provides software-as a-service that enables innovative communications technologies through its proprietary software platform. It provides a broad suite of data, voice, and managed solutions to business, enterprise and government customers.More

Articles & Videos

Aussie Broadband welcomes digital-first Buddy to the NBN market

Despite the new product's introduction, Aussie Broadband Ltd's shares dropped by more than 16% on news of a revised-down EBITDA.

15 Jul 2024 09:48 (AEST)

Aussie Broadband comes back humble, sells Superloop down to 12%

You may remember in the ancient history that was pre-Easter, Superloop and Aussie Broadband were involved in a strange kind of situation.

02 Apr 2024 10:39 (AEDT)

Aussie Broadband goes to court to scrap Superloop's sell-down notice

Only one day after Superloop accused Aussie Broadband of failing to correctly comply with Singaporean law, ABB has gone to the Federal Court.

19 Mar 2024 11:29 (AEDT)

Aussie Broadband to acquire Symbio via scheme implementation deed

Aussie Broadband (ASX:ABB) has entered into a scheme implementation agreement to acquire Symbio for $2.26 in cash and 0.192 ABB shares per share.

01 Nov 2023 12:19 (AEDT)



(20min delay)
Last
$3.73 		Change
0.010(0.27%) 		Mkt cap ! $1.100B
Open High Low Value Volume
$3.68 $3.73 $3.68 $134.4K 36.23K

Buyers (Bids)

No. Vol. Price($)
27 2645 $3.72
 

Sellers (Offers)

Price($) Vol. No.
$3.73 3665 30
View Market Depth
Last trade - 12.30pm 02/10/2024 (20 minute delay) ?
Last
$3.71 		  Change
0.010 ( 0.23 %)
Open High Low Volume
$3.69 $3.74 $3.69 13669
Last updated 12.49pm 02/10/2024 ?
ABB (ASX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
Maximus jumps 7% as it unveils latest gold drill hits at Eagles Nest; grades up to 15g/t Maximus Resources (ASX:MXR) has unveiled its latest drilling assay results at Eagles Nest, hitting gold downhole multiple assets.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.